Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980233229> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2980233229 endingPage "8" @default.
- W2980233229 startingPage "1" @default.
- W2980233229 abstract "Objective: We aimed to examine the outcomes associated with the mammalian target of rapamycin inhibitor (sirolimus or everolimus), (m-TORi) regimens in kidney transplant recipients (KTR) with primary diagnoses of hypertension.Methods: In this retrospective observational study, 187,381 adult KTRs were classified into the hypertension or non-hypertension cohort based on their primary renal diagnosis pre-transplant. Cox regressions were used to analyze the risks for death and graft loss associated with the following regimens: m-TORi with or without steroids combined with cyclosporine (m-TORi+CSA), mycophenolate (m-TORi+MPA) or tacrolimus (m-TORi+Tac); cyclosporine with or without steroids combined with mycophenolate (CSA+MPA); and other regimens.Results: The risk of death-with-graft-function did not differ between mTORi regimens in KTRs with a primary diagnosis of HTN [mTORi+CSA vs: mTORi+MPA (HR=0.88; 95% CI=0.68-1.14) and mTORi+Tac (HR=1.16; 95% CI=0.91-1.47); and mTORi+MPA vs. mTORi+Tac (HR=1.31; 95% CI=1.00-1.72)]. However, in KTRs with a primary diagnosis other than HTN, mTORi+CSA is associated with a lower risk of death-with-graft-function than mTORi+MPA or mTORi+Tac [mTORi+CSA vs. mTORi+MPA: HR=0.81; 95% CI=0.71-0.92] and [mTORi+CSA vs. mTORi+Tac: HR=0.76; 95% CI=0.66-0.87]. In both primary diagnosis cohorts, the risks of overall and death-censored graft loss are higher with m-TORi+MPA than the other m-TORi regimens.Conclusion: MTORi+MPA is associated with higher risks of graft loss regardless of pre-transplant primary diagnosis. MTORi+CSA is associated with a higher likelihood of survival with a functioning graft in KTRs with a non-HTN primary diagnosis, a benefit not seen among KTRs with a primary diagnosis of HTN. Therefore, outcomes associated with mTORi regimens vary with the pre-transplant primary diagnosis classification of hypertension or non-hypertension: these associations may be considered in mTORi regimen selection after kidney transplantation." @default.
- W2980233229 created "2019-10-18" @default.
- W2980233229 creator A5007108134 @default.
- W2980233229 creator A5014485507 @default.
- W2980233229 creator A5047514896 @default.
- W2980233229 creator A5061287999 @default.
- W2980233229 date "2018-01-01" @default.
- W2980233229 modified "2023-09-27" @default.
- W2980233229 title "Outcomes of Mammalian Target of Rapamycin Inhibitor Regimens in Kidney Transplant Recipients with Pre-Transplant Primary Diagnosis of Hypertension and Other Etiologies: An Observational Study" @default.
- W2980233229 hasPublicationYear "2018" @default.
- W2980233229 type Work @default.
- W2980233229 sameAs 2980233229 @default.
- W2980233229 citedByCount "0" @default.
- W2980233229 crossrefType "journal-article" @default.
- W2980233229 hasAuthorship W2980233229A5007108134 @default.
- W2980233229 hasAuthorship W2980233229A5014485507 @default.
- W2980233229 hasAuthorship W2980233229A5047514896 @default.
- W2980233229 hasAuthorship W2980233229A5061287999 @default.
- W2980233229 hasConcept C126322002 @default.
- W2980233229 hasConcept C126894567 @default.
- W2980233229 hasConcept C128057223 @default.
- W2980233229 hasConcept C159641895 @default.
- W2980233229 hasConcept C2777921159 @default.
- W2980233229 hasConcept C2779699572 @default.
- W2980233229 hasConcept C2780303639 @default.
- W2980233229 hasConcept C2909675724 @default.
- W2980233229 hasConcept C2911091166 @default.
- W2980233229 hasConcept C71924100 @default.
- W2980233229 hasConcept C72563966 @default.
- W2980233229 hasConceptScore W2980233229C126322002 @default.
- W2980233229 hasConceptScore W2980233229C126894567 @default.
- W2980233229 hasConceptScore W2980233229C128057223 @default.
- W2980233229 hasConceptScore W2980233229C159641895 @default.
- W2980233229 hasConceptScore W2980233229C2777921159 @default.
- W2980233229 hasConceptScore W2980233229C2779699572 @default.
- W2980233229 hasConceptScore W2980233229C2780303639 @default.
- W2980233229 hasConceptScore W2980233229C2909675724 @default.
- W2980233229 hasConceptScore W2980233229C2911091166 @default.
- W2980233229 hasConceptScore W2980233229C71924100 @default.
- W2980233229 hasConceptScore W2980233229C72563966 @default.
- W2980233229 hasIssue "1" @default.
- W2980233229 hasLocation W29802332291 @default.
- W2980233229 hasOpenAccess W2980233229 @default.
- W2980233229 hasPrimaryLocation W29802332291 @default.
- W2980233229 hasRelatedWork W1597697188 @default.
- W2980233229 hasRelatedWork W1889499446 @default.
- W2980233229 hasRelatedWork W1956878450 @default.
- W2980233229 hasRelatedWork W1998407875 @default.
- W2980233229 hasRelatedWork W2006179292 @default.
- W2980233229 hasRelatedWork W2010945184 @default.
- W2980233229 hasRelatedWork W2199346292 @default.
- W2980233229 hasRelatedWork W2517526646 @default.
- W2980233229 hasRelatedWork W2578703807 @default.
- W2980233229 hasRelatedWork W2596967257 @default.
- W2980233229 hasRelatedWork W2607470128 @default.
- W2980233229 hasRelatedWork W2623374552 @default.
- W2980233229 hasRelatedWork W2799859234 @default.
- W2980233229 hasRelatedWork W2944716244 @default.
- W2980233229 hasRelatedWork W2964644973 @default.
- W2980233229 hasRelatedWork W2994835897 @default.
- W2980233229 hasRelatedWork W3109356362 @default.
- W2980233229 hasRelatedWork W3128312120 @default.
- W2980233229 hasRelatedWork W3189215025 @default.
- W2980233229 hasRelatedWork W3197879707 @default.
- W2980233229 hasVolume "2018" @default.
- W2980233229 isParatext "false" @default.
- W2980233229 isRetracted "false" @default.
- W2980233229 magId "2980233229" @default.
- W2980233229 workType "article" @default.